Longitudinal follow-up of patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis

Haematologica

Volumn 89, Issue 2, 2004, Pages 183-188

  Imashuku, Shinsaku ^a   Teramura, Tomoko ^a   Tauchi, Hisamichi ^b   Ishida, Yasushi ^b   Otoh, Yoshiko ^c   Sawada, Machiko ^d   Tanaka, Haruki ^e   Watanabe, Arata ^f   Tabata, Yasuhiro ^g   Morimoto, Akira ^g   Hibi, Shigeyoshi ^g   Henter, Jan Inge ^h  

^a Kyoto City Institute of Health and Environmental Sciences   (Japan)

^b EHIME UNIVERSITY   (Japan)

^c EHIME PREFECTURAL CENTRAL HOSPITAL   (Japan)

^d UNIVERSITY OF FUKUI   (Japan)

^e OSAKA RED CROSS HOSPITAL   (Japan)

^f Nakadohri Hospital   (Japan)

^g KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^h KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Chronic active anti Epstein Barr virus antibody titer; Epstein Barr virus; Hematopoietic stem cell transplantation; Hemophagocytic lymphohistiocytosis

Indexed keywords

BUSULFAN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DEXAMETHASONE; ETOPOSIDE; IMMUNOGLOBULIN; MELPHALAN; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; THIOTEPA;

ADOLESCENT; ADULT; ARTICLE; BLEEDING; CAUSE OF DEATH; CHILD; CONTROLLED STUDY; DEATH; DISEASE COURSE; EPSTEIN BARR VIRUS; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HUMAN; INFANT; INFECTION; LEUKEMIA; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; METASTASIS; SURVIVAL; VIRUS REACTIVATION; CLINICAL TRIAL; COHORT ANALYSIS; CORD BLOOD STEM CELL TRANSPLANTATION; DRUG COMBINATION; GROWTH, DEVELOPMENT AND AGING; HISTIOCYTOSIS; IMMUNOTHERAPY; JAPAN; MORTALITY; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRESCHOOL CHILD; PROGNOSIS; PROSPECTIVE STUDY; REMISSION; TREATMENT OUTCOME; VIROLOGY; VIRUS ACTIVATION; VIRUS INFECTION;

ADOLESCENT; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COMBINED MODALITY THERAPY; CORD BLOOD STEM CELL TRANSPLANTATION; DEXAMETHASONE; DRUG THERAPY, COMBINATION; EPSTEIN-BARR VIRUS INFECTIONS; ETOPOSIDE; FEMALE; FOLLOW-UP STUDIES; HERPESVIRUS 4, HUMAN; HISTIOCYTOSIS, NON-LANGERHANS-CELL; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOTHERAPY; INFANT; JAPAN; MALE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROGNOSIS; PROSPECTIVE STUDIES; REMISSION INDUCTION; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VIRUS ACTIVATION;

EID: 2942572043     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Kawaguchi H, Miyashita T, Herbst H, Niedobitek G, Asada M, Tsuchida M, et al. Epstein-Barr virus-infected T lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome. J Clin Invest 1993;92:1444-50.
2. Su IJ, Chen RL, Lin DT, Lin KS, Chen CC. Epstein-Barr virus infects T-lymphocytes in childhood EBV-associated hemophagocytic syndrome in Taiwan. Am J Pathol 1994;144:1219-25.
3. Quintanilla-Martinez L, Kumar S, Fend F, Reyes E, Teruya-Feldstein J, Kingma DW, et al. Fulminant EBV (+) T-cell lymphoproliferative disorder following acute/ chronic EBV infection: a distinct clinicopathologic syndrome. Blood 2000;96:443-51.
4. Kawa K. Epstein-Barr virus-associated diseases in humans. Int J Hematol 2000;71:108-17.
5. Mitarnun W, Suwiwat S, Pradutkanchana J, Saechan V, Ishida T, Takao S, et al. Epstein-Barr virus-associated peripheral T-cell and NK-cell proliferative disease/lymphoma: clinicopathologic, serologic, and molecular analysis. Am J Hematol 2002;70:31-8.
6. Kasahara Y, Yachie A, Takei K, Kanegane C, Okada K, Ohta K, et al. Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Blood 2001; 98:1882-8.
7. Henter JI, Arico M, Egeler RM, Elinder G, Favara BE, Filipovich AH, et al. HLH-94 a treatment protocol for hemophagocytic lymphohistiocytosis. Med Pediatr Oncol 1997;28:342-7.
8. Henter JI, Samuelsson-Horne A, Arico M, Egeler RM, Elinder G, Filipovich AH, et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Histocyte Society. Blood 2002;100:2367-73.
9. Janka GE, Familial hemophagocytic lymphohistiocytosis. Eur J Pediatr 1983;140:221-30.
10. Aricò M, Janka G, Fischer A, Henter JI, Blanche S, Elinder G, et al. Hemophagocytic lymphohistiocytosis: report of 122 children from the International Registry: FHL Study Group of the Histiocyte Society. Leukemia 1996;10:197-203.
11. Sumegi J, Huang D, Lanyi A, Davis JD, Seemayer TA, Maeda A, et al. Correlation of mutations of the SH2D1A gene and Epstein-Barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease. Blood 2000;96:3118-25.
12. Imashuku S, Hibi S, Kuriyama K, Tabata Y, Hashida T, Iwai A, et al. Management of severe neutropenia with cyclosporin during initial treatment of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis. Leuk Lymphoma 2000;36:339-46.
13. Imashuku S. Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Crit Rev Oncol Hematol 2002; 44:259-72.
14. Imashuku S, Hibi S, Ohara T, Iwai A, Sako M, Kato M, et al. Effective control of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis with immunochemotherapy. Blood 1999;93:1869-74.
15. Imashuku S, Kuriyama K, Teramura T, Ishii E, Kinugawa N, Kato M, et al. Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. J Clin Oncol 2001;19:2665-73.
16. Telenti A, Marshall WF, Smith TF. Detection of Epstein-Barr virus by polymerase chain reaction. J Clin Microbiol 1990;28:2187-90.
17. Teramura T, Tabata Y, Yagi T, Morimoto A, Hibi S, Imashuku S. Quantitative analysis of cell-free Epstein-Barr virus genome copy number in patients with EBV-associated hemophagocytic lymphohistiocytosis. Leuk Lymphoma 2002;43:173-9.
18. Raab-Traub N, Flynn K. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 1986;47:883-9.
19. Imashuku S, Hibi S, Tabata Y, Itoh E, Hashida T, Tsunamoto K, et al. Outcome of clonal hemophagocytic lymphohistiocytosis: analysis of 32 cases. Leuk Lymphoma 2000;37:577-84.
20. Ueda I, Morimoto A, Inaba T, Yagi T, Hibi S, Sugimoto T, et al. Characteristic perforin gene mutations of haemophagocytic lymphohistiocytosis patients in Japan. Br J Haematol 2003;121:503-10.
21. Shinozaki K, Kanegane H, Matsukura H, Sumazaki R, Tsuchida M, Makita M, et al. Activation-dependent T cell expression of the X-linked lymphoproliferative disease gene product SLAM-associated protein and its assessment for patient detection. Int Immunol 2002;14:1215-23.
22. Arico M, Imashuku S, Clementi R, Hibi S, Teramura T, Danesino C, et al. Hemophagocytic lymphohistiocytosis due to germline mutations in SH2D1A, the X-linked lymphoproliferative disease gene. Blood 2001;97:1131-3.
23. Kitazawa J, Ito E, Arai K, Yokoyama M, Fukayama M, Imashuku S. Secondary acute myelocytic leukemia after successful chemotherapy with etoposide for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Med Pediatr Oncol 2001;37:153-4.
24. Imashuku S, Hibi S, Todo S, Sako M, Inoue M, Kawa K, et al. Allogeneic hematopoietic stem cell transplantation for patients with hemophagocytic syndrome (HPS) in Japan. Bone Marrow Transplant 1999; 23:569-72.
25. Imashuku S, Hyakuna N, Funabiki T, Ikuta K, Sako M, Iwai A, et al. Low natural killer activity and central nervous system disease as a high-risk prognostic indicator in young patients with hemophagocytic lymphohistiocytosis. Cancer 2002; 94:3023-31.
26. Hasegawa D, Sano K, Kosaka Y, Hayakawa A, Nakamura H. A case of hemophagocytic lymphohistiocytosis with prolonged remission after syngeneic bone marrow transplantation. Bone Marrow Transplant 1999;24:425-7.
27. Kogawa K, Lee SM, Villanueva J, Marmer D, Sumegi J, Filipovich AH. Perforin expression in cytotoxic lymphocytes from patients with hemophagocytic lymphohistiocytosis and their family members. Blood 2002;99:61-6.
28. Kimura H, Morita M, Yabuta Y, Kuzushima K, Kato K, Kojima S, et al. Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. J Clin Microbiol 1999;37:132-6.